Factors associated with vaccination intentions and uptake among pregnant women in the UK: A scoping review Authors: Mohammed Khudair, Stephanie L Swift, Kimberly Dienes, Yumitra A Kannan, Kavita Vedhara Published: 2026 ABSTRACT ABSTRACTThis scoping review aimed to identify factors associated with vaccination decisions among pregnant women in the UK, guided by the SAGE matrix on vaccine hesitancy, and explored differences between qualitative and quantitative findings and between vaccine intentions (attitudes) and actual uptake (behaviors). Embase®, MEDLINE®, PsycInfo, Web of Science, and Cochrane were searched; rapid review methodologies were applied. From 2,326 records, 49 primary studies were included (published 2010–2025). We identified 222 qualitative factors from 32 studies, and 114 quantitative factors from 30 studies. Qualitative studies frequently reported individual and group influences, particularly beliefs and attitudes about vaccine effectiveness and safety, and the role of healthcare professionals in decision-making. Quantitative studies highlighted sociodemographic influences, including older age, ethnicity, and lower social/economic deprivation. Factors found to be associated with vaccination intention vs. uptake were inconsistent, though these findings should be interpreted cautiously given the modest number of studies addressing this issue.KEYWORDS: Vaccine hesitancy, maternal vaccination, vaccine confidence, antenatal care, healthcare professionals, influenza, pertussis, respiratory syncytial virus, RSV, COVID-19 Introduction Pregnant women are at greater risk of preventable infectious diseases due to pregnancy-related reduced immune function.1,2 Maternal infections account for up to 50% of stillbirths and 25% of infant deaths, making them a major contributor to infant morbidity and mortality.2–4 Infectious diseases also place the mother at increased risk for pre-term birth, other complications and mortality.2,4 Vaccines are the primary vehicle for preventing infections during pregnancy and have been widely shown to be effective and safe for pregnant women.5,6 The National Health Service (NHS) in the United Kingdom (UK) routinely recommends that pregnant women receive vaccines against influenza (seasonal flu), pertussis (whooping cough) and respiratory syncytial virus (RSV).7,8 However, despite their established benefits, the uptake rates of these recommended vaccines remain suboptimal. Uptake rates in England in 2025 were reported as 72.9% for the pertussis vaccine,9 57.8% for the RSV vaccine,10 and 35% for the influenza vaccine.11 These rates indicate that many pregnant women are not receiving recommended vaccines even when offered as part of routine maternity care. As such, a comprehensive understanding of the factors associated with vaccine decision making among pregnant women in the UK is needed to inform the development of effective interventions to promote vaccine uptake. Key to understanding women’s vaccine choices during pregnancy is the construct of vaccine hesitancy. The World Health Organization (WHO) Strategic Advisory Group of Experts (SAGE) define vaccine hesitancy as a “delay in acceptance or refusal of vaccination despite availability of vaccination services. Vaccine hesitancy is complex and context specific, varying across time, place and vaccines.”12 An early conceptualization of vaccine hesitancy was outlined in their 3Cs model,13 which described hesitancy as being shaped by ‘confidence’ (a lack of trust in the effectiveness and safety of vaccines, the system that delivers them and the motivations of policymakers), ‘convenience’ (practical issues, such as physical availability, affordability etc.) and ‘complacency’ (not viewing diseases or vaccination as important).12,13 The SAGE later devised a larger conceptual framework in the form of a matrix,12 which organizes factors into contextual, individual and group, and vaccine/vaccination-specific influences, allowing a more nuanced examination across settings, vaccines and populations. As vaccine hesitancy is regarded to exist on a continuum from vaccine refusal to acceptance, it is necessarily influenced by a range of attitudes and beliefs, and external structural and contextual factors (e.g., access to health services, clarity of recommendations), all of which may contribute to vaccine uptake.12,14–16 In this way, vaccine hesitancy is clearly related to both vaccine intentions and vaccination behaviors (i.e., vaccine refusal and vaccine acceptance or uptake).15,17 For these reasons, we applied the SAGE matrix of vaccine hesitancy to categorize our findings. In addition, in recognition of the well-established ‘gap’ between intentions and behavior,18 we sought to explore whether there were reliable differences in the factors associated with intention versus the factors associated with behavior. We also considered evidence from quantitative and qualitative studies separately to explore whether and how methodology may be influencing our understanding of women’s vaccine decisions and, in turn, our approaches to intervention. Finally, as evidence suggests that vaccine decisions are influenced by different factors across geographic regions reflecting population sociodemographic characteristics, local service structure and organization, and differences in culture and communication,19–22 we applied a UK focus to better understand the reasons associated with vaccine decisions in pregnant women in the UK. In summary, the aims of this scoping review were to (1) identify factors associated with vaccine decisions among pregnant women in the UK and map them to the SAGE matrix, (2) examine differences in the factors identified between qualitative and quantitative studies and (3) explore whether and how factors associated with vaccine uptake differ from those associated with vaccination intention. The broader goal was to inform strategies to help increase vaccination uptake in pregnant women and to identify gaps in the literature where further research is needed. Materials and methods This review was guided by the Joanna Briggs Institute (JBI) Manual for Evidence Synthesis for scoping reviews23 and Cochrane rapid review methods guidance.24 The reporting in the current article was guided by the Preferred Reporting Items for Systematic reviews and Meta-analyses extension for Scoping Reviews (PRISMA-ScR).25 The completed PRISMA-ScR checklist is available in Appendix 1. No pre-registered or publicly available protocol was produced prior to conducting the current review. Systematic searches were conducted on the 26th July 2025 in five electronic databases, including Embase® (Ovid), MEDLINE® (Ovid), PsycInfo (APA PsycInfo), Web of Science (Clarivate) and the Cochrane library. The search queries used for each database can be found in Appendix 2. The search strategy sought studies including types of vaccines relevant to pregnancy, pregnancy population, hesitancy/attitudes/behavioral constructs and location. For Embase® and MEDLINE®, the search results were restricted by country (UK) using validated filters.26,27 No restrictions were applied based on date, study design or language. The search queries were checked by a second member of the review team. Relevant systematic reviews were tagged during screening to be used for reference checking to identify additional studies but were not included in the results synthesis. The reference lists of included studies were also checked for additional studies. The search results were de-duplicated using EndNote.28 After de-duplication, titles and abstracts for all records were screened for relevance. The full texts of relevant records were evaluated for eligibility based on pre-defined inclusion and exclusion criteria (Table 1). At both stages of screening, one reviewer screened all records, and a second independent reviewer screened 20% of the records in line with Cochrane rapid review guidelines.24 Any conflicts during the screening process were resolved through discussion. If non-English language studies were selected, they were tagged during screening and provided to the project team for a decision on whether translation would be needed. Table 1.Inclusion and exclusion criteria used to guide the study selection.ElementInclusion criteriaExclusion criteriaParticipantsPregnant people of any age eligible for influenza, RSV, pertussis or COVID-19 vaccines (in line with NHS recommendations of vaccines for pregnant women at the time of project initiation)Adult women pre-conceptionPost-partum mothersChildrenConceptAny reasons for vaccine hesitancy (e.g. fear of complications, mistrust etc.)Reasons mapped to the theoretical construct they relate to, where reported (e.g. Health Belief Model, Theory of Planned Behavior, 3C model, 5C model, 5A model)Characteristics associated with vaccine hesitancy (e.g. age, social class, ethnicity, education level)–ContextAny healthcare or non-healthcare setting–SourcePrimary research studies (quantitative or qualitative)Systematic reviewsScoping reviewsLetters, case studies/case reports, case series, guidelines, blogs, non-relevant reviews/editorials, editorials, commentaries, theses, conference abstracts published pre-2022GeographyUK (England, Scotland, Wales, Northern Ireland)Non-UK countriesLanguageNo restrictions – English and non-English language publications were included–DateNo date limits were applied– Inclusion and exclusion criteria used to guide the study selection. Pregnant people of any age eligible for influenza, RSV, pertussis or COVID-19 vaccines (in line with NHS recommendations of vaccines for pregnant women at the time of project initiation) Pregnant people of any age eligible for influenza, RSV, pertussis or COVID-19 vaccines (in line with NHS recommendations of vaccines for pregnant women at the time of project initiation) Adult women pre-conception Adult women pre-conception Post-partum mothers Post-partum mothers Children Children Any reasons for vaccine hesitancy (e.g. fear of complications, mistrust etc.) Any reasons for vaccine hesitancy (e.g. fear of complications, mistrust etc.) Reasons mapped to the theoretical construct they relate to, where reported (e.g. Health Belief Model, Theory of Planned Behavior, 3C model, 5C model, 5A model) Reasons mapped to the theoretical construct they relate to, where reported (e.g. Health Belief Model, Theory of Planned Behavior, 3C model, 5C model, 5A model) Characteristics associated with vaccine hesitancy (e.g. age, social class, ethnicity, education level) Characteristics associated with vaccine hesitancy (e.g. age, social class, ethnicity, education level) Primary research studies (quantitative or qualitative) Primary research studies (quantitative or qualitative) Systematic reviews Systematic reviews Scoping reviews Scoping reviews Letters, case studies/case reports, case series, guidelines, blogs, non-relevant reviews/editorials, editorials, commentaries, theses, conference abstracts published pre-2022 Letters, case studies/case reports, case series, guidelines, blogs, non-relevant reviews/editorials, editorials, commentaries, theses, conference abstracts published pre-2022 UK (England, Scotland, Wales, Northern Ireland) UK (England, Scotland, Wales, Northern Ireland) Non-UK countries Non-UK countries No restrictions – English and non-English language publications were included No restrictions – English and non-English language publications were included No date limits were applied No date limits were applied Data charting was done using a pre-prepared data charting table in Microsoft Excel.29 The table was reviewed by the project team for feedback and piloted with two included studies. One reviewer completed the data charting; 20% of studies were checked independently by another member of the review team in line with Cochrane rapid review guidelines.24 No risk of bias assessment was done for the current scoping review in line with JBI guidance.23 The following data were extracted from all included studies. Study details (authors, publication year, study dates, publication type, e.g., conference abstract) Study details (authors, publication year, study dates, publication type, e.g., conference abstract) Location (country within the UK and/or region) Location (country within the UK and/or region) Study design (e.g. cohort) and direction (e.g. prospective) Study design (e.g. cohort) and direction (e.g. prospective) Study aims/purpose Study aims/purpose Participant details and sample size Participant details and sample size Setting (healthcare vs. non-healthcare, details of recruitment) Setting (healthcare vs. non-healthcare, details of recruitment) Vaccine details (vaccine type, actual uptake or intent) Vaccine details (vaccine type, actual uptake or intent) Pregnancy status (e.g., confirmed or self-reported) Pregnancy status (e.g., confirmed or self-reported) Factors associated with vaccine decisions based on qualitative and quantitative methods (mapped to the SAGE matrix: contextual influences, individual and group influences, or vaccine- and vaccination-specific issues) Factors associated with vaccine decisions based on qualitative and quantitative methods (mapped to the SAGE matrix: contextual influences, individual and group influences, or vaccine- and vaccination-specific issues) Whether the factors were related to vaccine intention or actual vaccine uptake Whether the factors were related to vaccine intention or actual vaccine uptake Theoretical constructs: the reported theories as basis of the work Theoretical constructs: the reported theories as basis of the work Factors associated with vaccine decisions in pregnant women identified in both qualitative and quantitative studies were mapped to the WHO SAGE matrix.12 The matrix comprises three overarching themes of influence: contextual influences, individual and group influences, and vaccine- and vaccine-specific issues. Within each overarching theme, the matrix specifies categories of factors that represent distinct domains of influence (Table 2). The SAGE matrix was developed to identify factors associated with vaccine hesitancy in general populations. It has been suggested that it is possible to extend the SAGE matrix where a more detailed and nuanced understanding of the factors influencing vaccine decisions may be relevant as they may occur within sub-populations such as pregnant women.13 Therefore, a fourth theme was added to capture pregnancy-specific factors based on psychological, physiological and contextual issues associated with pregnancy. Factors based on quantitative and qualitative studies were synthesized and reported separately and later integrated in the discussion section. Factors derived from qualitative studies were synthesized at the level of themes and reported narratively. Factors were classified as barriers, enablers and potentially multidirectional based on their observed associations with vaccination decisions in pregnant women. Factors derived from quantitative studies were reported according to the direction of their association with vaccine uptake (i.e., increased uptake, decreased uptake, mixed evidence or no association) as reported in the included studies. Conceptually similar indicators representing the same underlying exposure were grouped into single factors (e.g. use of different social media platforms such as LinkedIn and Twitter). Moreover, we explored whether and how factors associated with vaccine uptake differed from those associated with vaccination intention, focussing on studies with quantitative designs. Factors were included if they have been assessed in both studies with vaccine uptake and studies with vaccine intention as outcomes. That is, if the selected factor had been considered in relation to either actual uptake or intention, but not both, then the relevant factor was not included in the comparison. A narrative summary was provided for this comparison. Figures were created using R.30 Table 2.The World Health Organization (WHO) SAGE matrix on vaccine hesitancy. Adapted from MacDonald et al.12SAGE matrix theme;DefinitionCategoriesContextual influences:Influences arising due to historic, socio-cultural, environmental, health system/institutional, economic or political factorsCommunication and media environmentInfluential leaders, immunization program gatekeepers and anti- or pro-vaccination lobbiesHistorical influencesReligion/culture/gender/socio-economicPolitics/policiesGeographic barriersPerception of the pharmaceutical industryIndividual and group influences:Influences arising from personal perception of the vaccine or influences of the social/peer environmentPersonal, family and/or community members’ experience with vaccination, including painBeliefs, attitudes about health and preventionKnowledge/awarenessHealth system and providers – trust and personal experienceRisk/benefit (perceived, heuristic)Immunization as a social norm vs. not needed/harmfulVaccine/vaccination-specific issues:Directly related to vaccine or vaccinationRisk/benefit (epidemiological and scientific evidence)Introduction of a new vaccine or new formulation or a new recommendation for an existing vaccineMode of administrationDesign of vaccination program/Mode of delivery (e.g., routine program or mass vaccination campaign)Reliability and/or source of vaccine supply and/or vaccination equipmentVaccination scheduleCostsThe strength of the recommendation and/or knowledge base and/or attitude of healthcare professionalsPregnancy-specific issuesPregnancy-specific issues influencing vaccine hesitancy The World Health Organization (WHO) SAGE matrix on vaccine hesitancy. Adapted from MacDonald et al.12 Communication and media environment Communication and media environment Influential leaders, immunization program gatekeepers and anti- or pro-vaccination lobbies Influential leaders, immunization program gatekeepers and anti- or pro-vaccination lobbies Historical influences Historical influences Religion/culture/gender/socio-economic Religion/culture/gender/socio-economic Politics/policies Politics/policies Geographic barriers Geographic barriers Perception of the pharmaceutical industry Perception of the pharmaceutical industry Personal, family and/or community members’ experience with vaccination, including pain Personal, family and/or community members’ experience with vaccination, including pain Beliefs, attitudes about health and prevention Beliefs, attitudes about health and prevention Knowledge/awareness Knowledge/awareness Health system and providers – trust and personal experience Health system and providers – trust and personal experience Risk/benefit (perceived, heuristic) Risk/benefit (perceived, heuristic) Immunization as a social norm vs. not needed/harmful Immunization as a social norm vs. not needed/harmful Risk/benefit (epidemiological and scientific evidence) Risk/benefit (epidemiological and scientific evidence) Introduction of a new vaccine or new formulation or a new recommendation for an existing vaccine Introduction of a new vaccine or new formulation or a new recommendation for an existing vaccine Mode of administration Mode of administration Design of vaccination program/Mode of delivery (e.g., routine program or mass vaccination campaign) Design of vaccination program/Mode of delivery (e.g., routine program or mass vaccination campaign) Reliability and/or source of vaccine supply and/or vaccination equipment Reliability and/or source of vaccine supply and/or vaccination equipment Vaccination schedule Vaccination schedule Costs Costs The strength of the recommendation and/or knowledge base and/or attitude of healthcare professionals The strength of the recommendation and/or knowledge base and/or attitude of healthcare professionals Pregnancy-specific issues influencing vaccine hesitancy Pregnancy-specific issues influencing vaccine hesitancy Results Study identification A total of 2,326 records were identified through the database searches. After de-duplication, the titles and abstracts of 1,875 records were screened. The full texts of 202 records were retrieved and evaluated for eligibility. Reference checking yielded another 11 eligible records. A total of 85 records were included, including 49 primary studies (across 55 records; some studies had more than one record),31–79 and 30 systematic reviews.21,22,80–106 Of the 49 included primary studies, four were conference abstracts.33,44,46,61 Figure 1 presents a full description of the study selection process. PRISMA flow diagram outlining the study selection process from databases and other sources. ti/ab = title and abstract screening stage. Study characteristics The study characteristics are presented in Table 3. The included studies were published between 2010 and 2025. Two studies did not provide dates.33,46 The sample sizes ranged between 10 and 260,744 pregnant women. Three studies did not report a sample size. Of the 49 included studies, 35 studies were conducted in single countries of the UK, including 29 (60%) studies conducted in England,31–35,37,39,42–44,46,50–53,57,58,61,63–67,70,73,76–79 three (6%) in Scotland,49,69,72 two (4%) in Wales59,60 and one (2%) in Northern Ireland.56 Eight (16%) studies were conducted in multiple countries within the UK,36,41,45,47,54,62,68,71 including one study that reported comparative datasets between the countries of the UK.47 Six (12%) studies were conducted in the UK, but did not specify their location.38,40,48,55,74,75 Figure 2 presents the distribution of the included studies across the UK. Table 3.Study characteristics.Study author, Year of publicationCountry(ies)Sample sizeStudy designSetting (Healthcare/non-Healthcare/Mixed);Recruitment; LocationPregnancy status (Self-reported/Confirmed)Vaccine(s)Vaccine uptake (Intent/Actual)Theoretical framework(s)Ambihaipahan, 202331ENG16Qualitative – Secondary analysis of semi-structured interviewsNon-healthcare;Online – Social media; Location NRSelf-reported;Potential participants were screened for eligibility, including delivering babies between 1st March 2020 and 1st March 2021 using NHS services in England.COVID-19NR/unclearNRAnderson, 202132ENG31Qualitative – Semi-structured interviewsNon-healthcare;Online/News – Social media, Local media; Bristol and surrounding areaSelf-reported;Potential participants were screened in an online form, including pregnancy status.Routine maternal vaccines, including influenza, pertussisVaccine intentNRBabaua, 202233ENG165Quantitative – Conference abstract;Cross-sectional surveyHealthcare;Antenatal clinics across Heartlands, Good Hope and Solihull HospitalsConfirmed;Participants were recruited in antenatal clinics.COVID-19BothNRBerendes, 202334ENG38Qualitative – Semi-structured interviewsMixed;Clinics and community – South London boroughs based on Index of Multiple Deprivation and ethnicitySelf-reported;Potential pregnant/post-partum participants were screened at recruitment and confirmed pregnancy status during interview.Mixed: Influenza, pertussis, COVID-19Vaccine uptake (actual)Critical realist paradigmBlakeway, 202235ENG1,328Quantitative – Retrospective cohortHealthcare;Clinical records – St George’s University Hospitals NHS Foundation Trust, LondonConfirmed;Yes – all gave birthCOVID-19Vaccine uptake (actual)NRBroad, 202536ENG & WAL1,061Quantitative – Cross-sectional survey;Health Security Agency SurveyNon-healthcare;Online – Parenting research panel (Bounty Media Limited); nationwideSelf-reported;Potential participants were screened in an online form, including pregnancy status.RSVVaccine intentNRByrne, 201837ENG191,533Quantitative – Retrospective cohortHealthcare;Clinical records – National vaccine coverage data (ImmForm); multiple countiesConfirmed;As recorded in clinical records.PertussisVaccine uptake (actual)NRCampbell, 201538NR587Quantitative – Cross-sectional surveyNon-healthcare;Online – Parenting research panel (Bounty Media Limited); nationwideSelf-reported;Potential participants were pre-registered and invited to complete an online form, including pregnancy status.PertussisVaccine intentNRCarlisle, 201939ENG4,817Quantitative – Retrospective cohortHealthcare;Clinical records – South London HospitalConfirmed;As recorded in clinical records.InfluenzaVaccine uptake (actual)NRCeulemans, 202140NR232Quantitative – Cross-sectional survey;Multinational studyNon-healthcare;Online – Social media and other websites commonly visited by pregnant women; Location NRSelf-reported;Collected as part of demographic section in large online survey.COVID-19Vaccine intentNRDasgupta, 202485ENG, SCO, WAL, NIR40Qualitative – Semi-structured interviewsMixed;Social media, relevant charities and existing participant pools in Clinical Research Network and wider RESILIENT study; nationwideSelf-reported;Potential participants were screened in an online form, including pregnancy status.COVID-19NR/unclearNRDavies, 202242ENG202Mixed methods – Cross-sectional survey, including open-ended questionsHealthcare;Maternity department at North Middlesex University Hospital (North London)Confirmed;At recruitment from antenatal clinics.COVID-19Vaccine uptake (actual)NRDonaldson, 201543ENG200Mixed methods – Cross-sectional survey, including open-ended questionsHealthcare;Antenatal clinic at Imperial Healthcare NHS Trust, LondonConfirmed;At recruitment from antenatal clinics.Mixed: Pertussis, influenzaVaccine uptake (actual)Precaution Adoption Process Model;Health Belief ModelDudhill, 202244ENG50Quantitative – Conference abstract;Cross-sectional surveyNR/unclear; Nottingham University HospitalsConfirmed;At recruitment, participants were postnatal inpatients.COVID-19Vaccine uptake (actual)NRFord, 201845ENG, SCO, WAL, NIR308Quantitative – Cross-sectional surveyNon-healthcare;Online – Parenting research panel (Mumsnet); Location NRSelf-reported;Collected as part of online survey.Mixed: Pertussis vs influenzaVaccine uptake (actual)NRFrise, 202346ENG1,012Quantitative – Conference abstract;Prospective cohort – Population-level dataHealthcare;Clinical records – Regional Observational data in Oxfordshire, UKConfirmed;As recorded in clinical records.COVID-19Vaccine uptake (actual)NRGu, 202447ENG & WAL vs ENG vs WAL311,990Quantitative – Retrospective cohortHealthcare;Clinical records – England: Oxford-Royal College of General Practitioners (RCGP) Research and Surveillance Center (RSC)Wales: Secure Anonymized Information Linkage (SAIL) Databank trusted research environment (TRE); Location NRConfirmed;As recorded in clinical records.Mixed: COVID-19 vs influenzaVaccine uptake (actual)NRHernandez, 202348NR500Quantitative – Cross-sectional survey;Multinational studyNon-healthcare;Online – Panels, communities and social media; Location NRSelf-reported;Collected as part of online survey.COVID-19Vaccine intentNRHilton, 201049SCO11Qualitative – Focus groupsNon-healthcare;Community – Universities, sports/leisure clubs, shops, local newspapers; Location NRSelf-reported;Collected as part of a short demographic questionnaire, including any current health issues – not specifically pregnancy.InfluenzaVaccine intentNRHusain, 202250ENG441Quantitative – Cross-sectional surveyHealthcare;Antenatal clinic at Wexham Park and Frimley Park Hospitals (District General Hospitals of Frimley Health NHS Foundation Trust)Confirmed;At recruitment from antenatal clinics.COVID-19Vaccine uptake (actual)NRIhenetu, 202451ENG39,213Quantitative – Retrospective cohortHealthcare;Clinical records – Northwest London (NWL) Whole Systems Integrated CareConfirmed;As recorded in clinical records.COVID-19Vaccine uptake (actual)NRKarafillakis, 202152ENGNRQualitative – Semi-structured interviewsMixed;Local research panels accessible to WIN/Gallup International Association (WIN/GIA) and posters at antenatal clinics; London and BirminghamNR/Unclear;Pregnant women were recruited, unclear how pregnancy status was collected.Maternal vaccines: Vaccines NRVaccine intentNRKilada, 202353ENG237Quantitative – Cross-sectional surveyNon-healthcare;Online – Local advertisement and social media (Liverpool City Region and North West UK)Self-reported;Collected as part of online survey. Pregnant women were targeted.Mixed: Influenza vs COVID-19BothNRKola-Palmer, 202454ENG, SCO, WAL, NIR, Ireland191Mixed methods – Cross-sectional survey, including open-ended questionsNon-healthcare;Online – Social media, Research panels (Mumsnet); nationwideSelf-reported;Collected as part eligibility criteria of online survey.COVID-19BothHealth Belief ModelMagee, 202455NR167Mixed methods – Cross-sectional survey, including open-ended questionsHealthcare;Online – Registered to the COVID Symptom Study Bank or current ZOE app users; Location NRSelf-reported;Collected as part of online survey.COVID-19Vaccine uptake (actual)NRMaisa, 201856NIR15Qualitative – Focus groups and one in-depth interviewNon-healthcare;On the streets; within reasonable traveling distance of BelfastConfirmed;Women were approached on-street and those meeting inclusion criteria, including being pregnant, were recruited.Mixed: Pertussis, influenzaVaccine uptake (actual)NRMcAuslane, 201857ENG1,128Quantitative – Cross-sectional surveyHealthcare;NHS maternity units; multiple countiesConfirmed;Women who delivered babies in maternity units were included.PertussisVaccine uptake (actual)NRMcQuaid, 201658ENG14Qualitative – Focus groups and interviewsHealthcare;At clinics upon informing midwives and GPs of their pregnancy; Oxford University Hospital NHS TrustConfirmed;At recruitment of women who were receiving antenatal care.Maternal vaccines: Vaccines NRVaccine intentNRMhereeg, 202359WAL25,111Quantitative – Retrospective cohortHealthcare;Clinical records – Secure Anonymized Information Linkage (SAIL) Databank; Location NRConfirmed;As recorded in clinical records.COVID-19Vaccine uptake (actual)NRMoukarram, 201260WAL200Quantitative – Cross-sectional surveyHealthcare;Antenatal clinic at Royal Gwent HospitalConfirmed;At recruitment, the survey was conducted in a consultant-led antenatal clinic.InfluenzaVaccine intentNRNair, 202261ENG86Quantitative – Conference abstract;Cross-sectional clinical auditHealthcare;At clinics – West Kent community perinatal mental health teamConfirmed;At recruitment, the survey was conducted in West Kent perinatal mental health community team.COVID-19BothNROakley, 202162ENG, SCO, WAL, NIRNRQuantitative – Retrospective cohortHealthcare;Clinical records – Public Health England, Public Health Scotland, NHS Wales and Health and Social Care Northern Ireland; Location NRNR/Unclear;Unclear how pregnant women were assigned from a databaseInfluenzaVaccine uptake (actual)NRParsons, 202463ENG43Qualitative – Semi-structured interviewsMixed;By midwives at participating hospitals, or by community group leaders; Location NRConfirmed;Participants were informed of the study by midwives and recruited at participating hospitals, or by community group leaders for pregnant women.Mixed: Influenza, pertussis, COVID-19BothIllness risk representation frameworkParsons, 202264ENG411Quantitative – Single-arm quasi-experimental designNon-healthcare;Online – Qualtrics Online Panel; Location NRSelf-reported;Potential participants were pre-registered in Qualtrics participant pool and indicated their pregnancy.InfluenzaBothNRRalph, 202265ENG20Mixed methods – Retrospective cross-sectional evaluation of clinical records and semi-structured interviewsHealthcare;Clinical records – the Vaccine Referral Database; Location NRConfirmed;Pregnant women registered as referred and receiving antenatal care were selected and recruited to the study.Mixed: Pertussis, influenzaVaccine uptake (actual)Health Belief ModelRazai, 202566ENG21Qualitative – Semi-structured interviewsHealthcare;Through general practice electronic systems and a GP; Greater London areaConfirmed;Pregnant women registered in GP electronic databases or receiving care were selected and recruited to the study.Mixed: Influenza, pertussis, COVID-19Vaccine uptake (actual)Capability, Opportunity, Motivation-Behavior (COM-B) model; 3-Ps modelRyan, 202067ENG282Quantitative – Randomized controlled trial;Three arms: (a) disease risk, (b) myth busting (c) controlNon-healthcare;Online – Social media (Facebook, Netmums); Location NRSelf-reported;Collected as part of online survey.PertussisBothTheory of Planned Behavior modelSammon, 201368ENG, SCO, WAL54,694Quantitative – Retrospective cohortHealthcare;Clinical records – UK General practice Research Database; Location NRConfirmed;As recorded in clinical records.InfluenzaVaccine uptake (actual)NRSim, 201169SCO10Qualitative – Semi-structured interviewsHealthcare;Antenatal clinics in Lothian, ScotlandConfirmed;Pregnant women were recruited from routine antenatal settings in Lothian.InfluenzaBothNRSkirrow, 202271ENG, SCO, WAL, NIR1,181Mixed methods – Cross-sectional survey and semi-structured interviewsNon-healthcare;Online – Social media, Maternity Voices Partnerships, Mumsnet; multiple countiesSelf-reported;Collected as part of online survey.Mixed: COVID-19 vs pertussisBothNRSkirrow, 202170ENG1,501Mixed methods – Cross-sectional clinical records and semi-structured interviewsHealthcare;Antenatal clinic including midwife-led vaccine clinic at Imperial College Healthcare NHS Trust, LondonConfirmed;Pregnant women were recruited at an antenatal clinic.Mixed: Pertussis, influenzaVaccine uptake (actual)NRStock, 202272SCO130,875Quantitative – Prospective cohortHealthcare;Population-level clinical records (The COVID-19 in Pregnancy in Scotland (COPS) study); Location NRConfirmed;Ongoing pregnancies were identified using antenatal booking appointment data.COVID-19Vaccine uptake (actual)NRTessier, 201873ENGNRQuantitative – Cross-sectional ecologicalHealthcare;Clinical records – Public Health England commissioned website, ImmForm; multiple countiesConfirmed;As recorded in clinical records – Pregnant women made up one of the subgroups in the dataset.InfluenzaVaccine uptake (actual)NRUKHSA, 202174ENG139,824Quantitative – Retrospective cohortHealthcare;Clinical records – National Immunization Management Service (NIMS) and the Hospital Episode Statistics (HES); Location NRConfirmed;As recorded in clinical records.COVID-19Vaccine uptake (actual)NRVousden, 202175NR1099Quantitative – Prospective cohortHealthcare;Clinical records – UK Obstetric Surveillance System (UKOSS); nationwideConfirmed;As recorded in clinical records.InfluenzaVaccine uptake (actual)NRWalker, 202176ENG220,222Quantitative – Retrospective cohortHealthcare;Clinical records – Clinical Practice Research Datalink (CPRD); nationwideConfirmed;As recorded in clinical records.Mixed: Pertussis vs influenzaVaccine uptake (actual)NRWilcox, 201977ENG314Quantitative – Cross-sectional surveyHealthcare;Antenatal clinics at University Hospital Southampton NHS Foundation Trust, Oxford University Hospitals NHS Foundation Trust, University Hospitals Bristol NHS Foundation Trust, and St George’s University Hospitals NHS Foundation Trust, LondonConfirmed;Pregnant women attending for routine antenatal care were recruited in-person by members of the study team.Mixed: RSV vs influenza vs pertussisVaccine intentNRWilson, 201978ENG40Qualitative – In-depth interviews, Hackney, LondonMixed;9 parent-toddler groups; 4 community centers and migrant support groups; 3 GP practices; and 2 community antenatal clinics; Hackney, LondonConfirmed;Pregnant women attending GP care, identified by healthcare professionals. From other sites, pregnant women were recruited in person by researcher.Maternal vaccines: Vaccines NRVaccine intentNRWoodcock, 202379ENG260,744Quantitative – Retrospective cohortHealthcare;Clinical records – The Northwest London Discover database and the Clinical Practice Research Datalink (CPRD) primary care databaseConfirmed;As recorded in clinical records.InfluenzaVaccine uptake (actual)NRNR = Not reported; ENG = England; SCO = Scotland; WAL = Wales; NIR = Northern Ireland; GP = General Practitioner; NHS = National Health Service. Study characteristics. NR = Not reported; ENG = England; SCO = Scotland; WAL = Wales; NIR = Northern Ireland; GP = General Practitioner; NHS = National Health Service. Distribution of the included studies across the UK, including studies conducted in multiple countries and studies not specifying a study location within the UK. Of the 49 included studies, 32 (65%) had a quantitative design, of which 30 studies were observational, including 16 (33%) cross-sectional33,36,38,40,42–45,48,50,53,57,60,61,65,77 and 14 (29%) longitudinal studies.35,37,39,46,47,51,62,68,72–76,79 Two (4%) studies were experimental, including one randomized controlled trial67 and one single-arm intervention.64 Twelve (24%) studies had a qualitative design and employed a thematic analysis.31,32,34,41,49,52,56,58,63,66,69,78 Five (10%) studies had a mixed methods design,54,55,59,70,71 involving cross-sectional designs and qualitative thematic analyses of semi-structured interviews and surveys with open-ended questions. In 29 of the 49 studies (59%), participants were recruited in healthcare settings,33,35,37,39,41–43,46,47,50,51,55,57–62,65,68–70,72–77,79 14 (29%) in non-healthcare settings (e.g., through online forums),31,32,36,38,40,45,48,49,53,54,56,64,67,71 five (10%) in mixed healthcare and non-healthcare settings34,52,63,66,78 and in one (2%) study, the setting was not reported.44 Pregnancy status was verified in 30 of the 49 studies (61%) either directly at recruitment for women recruited from healthcare settings or through clinical databases.33,35,37,39,42–44,46,47,50,51,56–61,63,65,66,68–70,72,74–79 For 17 (35%) studies, the pregnancy status was self-reported,31,32,34,36,38,40,41,45,48,49,53–55,64,67,71 mainly through online surveys. In two (4%) studies, pregnancy status was unclear or not reported – one study was based on a secondary analysis of interview data from a larger study,52 and one study was based on data from publicly available clinical databases.62 Of the 49 included studies, 17 (35%) reported exclusively on COVID-19 vaccines,31,33,35,40–42,44,46,48,50,51,54,55,59,61,72,74 10 (20%) on influenza vaccines,39,49,60,62,64,68,69,73,75,79 four (8%) on pertussis vaccines37,38,57,67 and one (2%) on RSV vaccines.36 Another 17 (35%) studies reported on multiple vaccines, including four reporting on any maternal vaccines,32,52,58,78 three on COVID-19, influenza and pertussis vaccines,34,63,66 and four on influenza and pertussis vaccines.43,56,65,70 Six studies reported comparative datasets between vaccine types, including two studies comparing pertussis vs influenza vaccines,45,76 two comparing COVID-19 vs influenza vaccines,47,53 one comparing COVID-19 vs pertussis vaccines,71 and one comparing RSV vs influenza vs pertussis vaccines.77 Figure 3 presents the distribution of vaccine types across the included studies. The distribution of vaccine types reported across the included studies, including studies reporting multiple vaccines and studies reporting comparative datasets of two or more vaccines. Actual vaccine uptake was reported in 27 (55%) studies,34,35,37,39,42–47,50,51,55–57,59,62,65,66,68,70,72–76,79 12 (25%) studies reported on vaccine intentions,32,36,38,40,48,49,52,58,60,71,77,78 and eight (16%) studies reported on both vaccine uptake and intention.33,53,54,61,63,64,67,69 Two (4%) studies did not report whether the data were based on vaccine uptake or intention.31,85 Seven of the 49 included studies (14%) reported single or combinations of theoretical frameworks as the basis for their studies. The theoretical frameworks included the Critical Realist Paradigm,34 the Precaution Adoption Process Model,43 the Health Belief Model,43,54,65 the Illness risk representation framework,63 the COM-B Model and the 3-Ps Model66 and the Theory of Planned Behavior.67 Factors associated with vaccination decisions in pregnant women – qualitative assessment Of the 49 included studies, 32 reported factors associated with vaccine decisions in pregnant women in the UK based on qualitative thematic analyses.31–34,36,38,40–44,48–50,52–56,58–61,63,65–67,69–71,77,78 A total of 222 factors were identified, among which 142 were barriers, 24 were enablers and 56 were potentially multidirectional. Appendix 3 presents the full list of identified factors. Figure 4 presents the cumulative number of studies reporting factors associated with vaccine decisions based on qualitative analyses. The factors were mapped onto the WHO SAGE matrix themes and categories. These are presented according to the size of the associated evidence base i.e., from most to least commonly reported across studies. Overview of the cumulative number of studies reporting on each theme of the WHO SAGE matrix on vaccine hesitancy. Based on a qualitative synthesis of factors reported in 32 of the 49 included studies. Color intensity represents number of studies. Contextual influences Contextual influences on vaccine decisions were reported in 25 studies,31,32,34,36,38,41,43,44,48–50,52,55,56,58,60,63,65–67,69–71,77,78 with “communication and media environment” identified most commonly (n = 21 studies). “Communication and media environment”31,32,34,38,41,43,44,48,50,52,55,56,58,60,63,65,66,69,71,77,78 included 16 factors, predominantly concerning a perceived lack of clear, consistent and pregnancy-specific communication around vaccination. This was based on conflicting and limited guidance and communication from healthcare professionals/the healthcare system, particularly during the COVID-19 pandemic. Misinformation from the media, social media and messaging from institutions (healthcare system/government) were reported as increasing fear and uncertainty, where misinformation was seen as not supporting pregnant women’s informed decisions around vaccination. The use of general health information systems to provide information about routine maternal vaccines were suggested to support informed decisions around vaccination; particularly for women who actively seek information about maternal vaccination using media sources and the internet. “Geographic barriers”34,36,56,63,65,67,71,77,78 included nine factors relating to structural/organizational issues, including vaccination service availability, attending additional appointments, childcare constraints, service disruptions (due to COVID-19), and variability between geographical healthcare settings. For example, ease of access to vaccines when integrated into routine antenatal care or provided in convenient settings may increase uptake, but when access required additional appointments or complex service navigation, uptake may be hindered. “Historical influences” 41,49,52,56,58,65,69 included six factors concerning fear and mistrust of vaccines due to historical controversies and medical scandals, such as those related to the MMR vaccine and fears regarding autism and thalidomide. This created concerns among pregnant women around vaccine safety and potential harm to the fetus due to potential side effects. “Politics and policies”34,48,55,69–71,78 included 13 factors, involving mistrust in governmental and health authorities, skepticism regarding vaccine development and approval processes and trust in information provided by the healthcare system. Additionally, factors related to frustrations with disorganized or inefficient healthcare systems; particularly the structure and organization of maternal vaccine services, including access pathways and trust in the NHS as a publicly funded healthcare system (not profit seeking). These factors were described as undermining confidence in vaccination recommendations among pregnant women. “Religion, culture, gender, and socio-economic factors”43,55,56,71,77,78 included five factors concerning cultural and religious beliefs, language barriers, and family dynamics, including partner and community views. This was reported as shaping perceptions of vaccine safety, (mis)trust and acceptability among pregnant women. “Pharmaceutical industry”36,52,71 included two factors concerning mistrust in the pharmaceutical industry and beliefs that doctors could make dishonest vaccine recommendations based on profit rather than evidence. These factors were reported as contributing to skepticism about vaccine safety and necessity during pregnancy. “Influential leaders, gatekeepers, and anti- or pro-vaccination lobbies”34 included eight factors focussing on structural features of maternity care. This included how antenatal services were organized and how vaccination opportunities were embedded within routine care pathways, indirectly shaping access and uptake. Individual and group influences Individual and group influences was the largest theme emerging in the included qualitative studies, reported in 31 studies.32–34,36,38,40–44,48–50,52–56,58–61,63,65–67,69–71,77,78 The sub-themes of beliefs and attitudes about health and prevention, and risk/benefit perceptions were the largest categories with factors identified in 22 and 24 studies, respectively. “Risk-benefit perceptions (perceived/heuristic)”34,36,38,41,43,44,48–50,52,54–56,58–61,63,65,66,69–71,77 included 14 factors concerning weighing of perceived benefits against potential risks of vaccines and fears of the vaccine against fear of the disease and anticipated future regret. Factors related to concerns regarding vaccine effectiveness and safety for the mother and fetus, including uncertainty around long-term side effects, especially for newer vaccines such as COVID-19 and RSV. Fear, anxiety, anticipated guilt, and perceived responsibility to protect the fetus were reported as reinforcing hesitancy. Other factors included a perceived lack of evidence for the effectiveness and benefit of vaccines, and perceptions of low personal susceptibility to infectious diseases or severity of the diseases in question. “Beliefs and attitudes about health and prevention”32–34,38,42–44,48,50,52,54–56,59,63,65,67,69–71,77,78 included 19 factors related to beliefs that natural immunity was superior, overmedication of pregnant women and perceived low risk of illness without vaccines. The factors also included concerns and risk-benefit perceptions about vaccine safety and effectiveness for the fetus. “Health system and providers – trust and personal experience”36,41,43,48–50,52,56,61,65–67,69–71,78 included 19 factors, including those related to healthcare professionals, such as limited encouragement from familiar healthcare professionals, limited trust due to lack of continuity with key healthcare professionals (e.g., midwives), perceived judgment or dismissal of concerns during antenatal appointments, and lack of transparency around vaccine safety, particularly for COVID-19 vaccines. Additionally, factors related to access to trusted sources of information, positive prior experiences of care, and clear, supportive recommendations from trusted healthcare professionals (particularly doctors) were often described as important influences for decision making around maternal vaccination. Factors were also related to relationships with healthcare professionals, a desire for impartial and personalized counseling, and trust in the wider health system, which could influence the quality of communication and support, particularly for marginalized communities. “Experience with past vaccination”34,43,52,56,58,61,63,65–67,69,71,77,78 included 17 factors relating to own past personal experiences with illness and vaccination. This included beliefs around immunity due to prior illness or vaccination, perceptions of low disease severity, and prior experiences of healthy pregnancies without vaccination. Factors also related to social influences of partners, family members, and other pregnant or previously pregnant women, either reinforcing hesitancy or promoting acceptance. These were attitudes toward vaccination were formed based on individual health histories and awareness of vaccinations during pregnancy. “Knowledge and awareness”32,34,40,41,43,52,53,55,56,63,65,69,71 included 14 factors related to a limited understanding of how vaccines work and a perception that vaccination represents an unacceptable risk during pregnancy. Additionally, factors related to sources of knowledge (healthcare professionals, family, friends, websites and social media), awareness specifically of maternal vaccination and knowledge of vaccination availability. One factor suggested that knowledge-seeking behaviors and having the desire and skills to find information about infectious diseases and maternal vaccination may increase uptake. “Immunization as a social norm vs. not needed/harmful”33,34,38,43,50,52,56 included six factors mostly reflecting ideological opposition to vaccination, including beliefs that vaccines are unnecessary or harmful, believing in natural immunity, and skepticism regarding the effectiveness of vaccines. Additionally, cultural norms were described as influencing decisions for vaccination. Vaccine- and vaccination-specific issues Vaccine and vaccination-specific issues were reported in 24 studies.31,34,36,41–44,49,50,52,54–56,58–60,63,65,66,69–71,77,78 Within this theme the role of healthcare professionals was the largest category with factors identified from 21 studies. None of the included studies reported factors under the categories “mode of administration”, “reliability and/or source of vaccine/equipment supply” or “costs”. “Role of healthcare professionals”31,34,41–43,49,50,52,54–56,58,60,63,65,66,69–71,77,78 included 27 factors, predominantly relating to a lack of encouragement to get vaccinated or not being offered vaccination at all, insufficient or unclear information and guidance, limited time for discussion, lack of continuity of care, and perceived gaps in healthcare professionals’ knowledge or confidence when discussing vaccination in pregnancy. Other factors concerned clear and consistent recommendations, effective messaging and personalized counseling, including opportunities for direct, meaningful discussion with trusted healthcare professionals, particularly midwives. “Introduction of a new vaccine or new formulation”31,34,36,41,42,44,49,50,54,55,58,59,63,65,66,69,71,77 included 16 factors reflecting concerns about vaccine novelty, short development timelines, unfamiliar or novel technologies, and uncertainty around long-term safety and effectiveness during pregnancy. Additionally, factors related to inconsistent or changing government and healthcare system guidance, mixed or misleading messages, limited information from NHS trusts, and difficulties keeping up with evolving recommendations, including changes in vaccination timing during pregnancy. Factors also related to routine recommendation of vaccination, which could promote uptake as part of routine procedures. “Risk-benefit (epidemiological and scientific evidence)”34,36,42–44,50,58,63,66,69–71 included 16 factors related to gaps in pregnancy-specific research, particularly regarding long-term safety and effectiveness, lack of clarity in available information, and insufficient engagement with women’s concerns in information from the healthcare system (i.e., NHS). Additionally, factors related to availability of high-quality and accessible evidence on the symptoms and severity of diseases and the effectiveness and side effects of vaccines. Discussions with healthcare professionals to support informed and personalized decision-making as part of vaccination programs targeting pregnant women were reported as supporting vaccine uptake. Pregnant women’s passive and active engagement in the vaccination decision-making process could either facilitate or impede uptake depending on the level of clarity or certainty in vaccine recommendations. “Vaccination schedule”59,63,71 included factors related to changes in advice and information during the pregnancy, preferences to delay vaccination until later in pregnancy or after pregnancy due to perceived lower risks of adverse effects, and a reduced likelihood that women would get vaccinated in the first trimester, particularly for influenza vaccination. “Design of vaccine program/mode of delivery”34,77 included eight factors related to limited accessibility of information, including accessible formats (i.e., hard copy vs. digital formats) which could result in digital exclusion, and unmet needs for people for whom English is not their first language. One indicated an increased likelihood of acceptance if a vaccine was routinely recommended. Additionally, factors included the desire for clearer provider recommendations; opportunities for a dialogue regarding vaccination and requesting additional information; and for some women it may be preferable to make the decisions around vaccinations passive (i.e., where vaccines are considered routine, unless they choose to opt out of it). Pregnancy-specific issues “Pregnancy-specific issues”31,32,38,55,77 included three factors around COVID-19 pandemic restrictions impacting antenatal services, not wanting to be vaccinated during pregnancy and risks associated with non-singleton pregnancies. Factors associated with vaccination decisions in pregnant women – quantitative assessment Of the 49 included studies, 30 studies reported factors associated with vaccine decisions in pregnant women in the UK based on quantitative analyses.35–37,39,42–48,50,51,53,54,57,59,62,64,67,68,70–77,79 A total of 114 factors associated with vaccine decisions in pregnant women in the UK were identified across these studies. Of the 30 studies, 28 reported contextual influences,35–37,39,42–48,50,51,53,54,57,59,62,68,70–77,79 12 reported individual and group-influences35,36,42,45,48,53,54,64,67,72,76,77 and 15 reported pregnancy-specific issues.35,36,39,43,45,48,53,54,57,68,70,71,75–77 None of the studies reported vaccine or vaccination-specific issues. Figure 5 presents the cumulative number of studies reporting factors associated with vaccine decisions in pregnant women in the UK mapped across the SAGE matrix. In the current section factors are listed and their associations with vaccine uptake as reported by the individual studies are summarized following the SAGE matrix, including contextual influences (Table 4), individual and group influences (Table 5) and pregnancy-specific issues (Table 6). Appendix 4 includes the full list of identified factors based on quantitative methods. Overview of the cumulative number of studies reporting on each theme of the WHO SAGE matrix on vaccine hesitancy. Based on a quantitative analysis of factors reported in 30 of the 49 included studies. Color intensity represents number of studies. Table 4.Quantitative factors associated with vaccine decisions during pregnancy in the UK. The factors were mapped to the SAGE theme contextual influences and their respective categories: communication and environment, Influential leaders, gatekeepers and anti- or pro-vaccination lobbies, disease- and disability-related, and geography or timing. For studies with no evidence, results were not significant; the direction of numerical difference was reported, if available.Factor (n studies)Increased uptake(n studies);ReferencesReduced uptake(n studies);ReferencesMixed evidence(n studies);ReferencesNo evidence(n studies);ReferencesCommunication and environment (n = 2)Frequency of using social networking sites145 Frequency of using social media to gather info on vaccines in pregnancy 1↓45Believed social media influenced them not to be vaccinated 145 Used social media for vaccine information 1↓45Has a smartphone 1Ø53Use of specific social networking sites (e.g., Facebook, Twitter) or messaging platforms (e.g., WhatsApp) 145 Influential leaders, gatekeepers and anti- or pro-vaccination lobbies (n = 3)Use of pregnancy-specific network sites for vaccine information 145 Use family or friends for vaccine information 145 Peer influences154 Discussed vaccination with partner/family member 1↓53Partner’s vaccination intent154 Religion/culture/gender/socio-economic factors (n = 27)Older age1211,15,18,20,23,27,30,33,35,47,52,55 1537↑21,24,46,48,50,51,532Ø36,68White or Asian ethnicity1411–13,15,18,20,27,33,35,46,47,52,53,55 247,536↑19,21,22,26,49,501Ø54Has a religion (or is Jewish/Muslim) 136 1↓ 73Most deprived areas 1011–13,20,23,27,35,49,52,55 5↓ 33,44,46,48,501Ø40Higher education level154 2↑45,53More advantaged/professional occupation 2↑53,75Higher income254,71 1↑53Marital status (single) 1↓752Ø45,54Single parent 136 Larger household size 147153 Household vaccination status (at least one member of household is vaccinated)142 Current/former smoker 359,68,75 2↓35,53Alcohol use during pregnancy 168 1↑35Speaks/fluent in English142 1↑39Higher level of exercise 1↑53Disease- and disability-related (n = 12)Disability 1↓36Risk group for vaccination354,68,76 Co-/muti-morbidities (any)348,58,62 1471Ø75Depression159 Living different diseases (e.g., asthma, diabetes, cardiovascular disease)335,51,79 3Ø35,51,591↓75Obesity335,51,79 247,772Ø68,75Underweight 247,76 1Ø68Geography or timing (n = 13)Rural location (vs. urban)247,73 Location in the UK (e.g., region, country)813,33,38,44,47,49,52,53 1↑621Ø45Flu season253,79 1↑68Season (Spring, Summer, Autumn, Winter)139 1↑73Year176 ↑ = Not statistically significant, numerical evidence in favor of increased uptake.↓ = Not statistically significant, numerical evidence in favor of reduced uptake.↔ = Not statistically significant, mixed or inconsistent evidence.Ø = No evidence. Quantitative factors associated with vaccine decisions during pregnancy in the UK. The factors were mapped to the SAGE theme contextual influences and their respective categories: communication and environment, Influential leaders, gatekeepers and anti- or pro-vaccination lobbies, disease- and disability-related, and geography or timing. For studies with no evidence, results were not significant; the direction of numerical difference was reported, if available. ↑ = Not statistically significant, numerical evidence in favor of increased uptake. ↓ = Not statistically significant, numerical evidence in favor of reduced uptake. ↔ = Not statistically significant, mixed or inconsistent evidence. Ø = No evidence. Table 5.Quantitative factors associated with vaccine decisions during pregnancy in the UK. The factors were mapped to the SAGE theme Individual and group influences and their respective categories: experience with past vaccination, beliefs and attitudes, knowledge and awareness, health system and providers – trust and personal experience, and risk/benefit (perceived). For studies with no evidence, results were not significant; the direction of numerical difference was reported, if available.Factor (n studies)Increased uptake(n studies);ReferencesReduced uptake(n studies);ReferencesMixed evidence(n studies);ReferencesNo evidence(n studies);ReferencesExperience with past vaccination (n = 7)Prior experience with the infectious organism177 1Ø54Prior flu vaccination137,54 Received vaccination in prior pregnancy145 Received a vaccine during current/last pregnancy (flu or whooping cough)345,53,71 1↑541Ø54Routinely recommended vaccine 1↑77Had antenatal COVID19/being COVID-19 positive148 1↑35Beliefs and attitudes (n = 7)Perceived benefits of vaccination167 Perceived susceptibility and severity of disease336,54,64 2↑64,771Ø77Perceived barriers and control154 1Ø67Anticipated regret at not getting vaccine154 Intent to get a vaccine167 Influence of parent/doctor/best friend attitudes167 Knowledge and awareness (n = 3)Familiarity with infectious disease 1↑77Aware of why receive vaccines 145 Shielded during COVID pandemic 153 Health system and providers – trust and personal experience (n = 5)Information source (e.g., GP, midwife, other healthcare professionals, NHS Website)436,42,45,76 1451Ø45Healthcare professional influence (e.g., GP, midwife)154 Government influence154 Trust in authorities154 Risk/benefit (perceived) (n = 2)Perception of vaccine benefit154 Perception of vaccine risk154 Intention to have flu vaccine164 Adherence to public health guidelines 1Ø54↑ = Not statistically significant, numerical evidence in favor of increased uptake.↓ = Not statistically significant, numerical evidence in favor of reduced uptake.↔ = Not statistically significant, mixed or inconsistent evidence.Ø = No evidence. Quantitative factors associated with vaccine decisions during pregnancy in the UK. The factors were mapped to the SAGE theme Individual and group influences and their respective categories: experience with past vaccination, beliefs and attitudes, knowledge and awareness, health system and providers – trust and personal experience, and risk/benefit (perceived). For studies with no evidence, results were not significant; the direction of numerical difference was reported, if available. ↑ = Not statistically significant, numerical evidence in favor of increased uptake. ↓ = Not statistically significant, numerical evidence in favor of reduced uptake. ↔ = Not statistically significant, mixed or inconsistent evidence. Ø = No evidence. Table 6.Quantitative factors associated with vaccine decisions during pregnancy in the UK. The factors were mapped to the theme pregnancy-specific issues, which was added to the SAGE matrix for the purpose of the current review. For studies with no evidence, results were not significant; the direction of numerical difference was reported.FactorIncreased uptake(n studies);ReferencesReduced uptake(n studies);ReferencesMixed evidence(n studies);ReferencesNo evidence(n studies);ReferencesReproductive history and number of existing children615,21,33,44,46,52 3↑54,75,771↓53Pregnancy risk and complications 1533↑35,43,751Ø35Later stages of pregnancy339,71,77 3↑53,54,681↓36Estimated delivery date in July-September 175 Antenatal health behaviors and medication 1531↑35Pregnancy status (pregnant vs post-partum)148 1451↓36Planned pregnancy139 Multiple pregnancy 1↑75↑ = Not statistically significant, numerical evidence in favor of increased uptake.↓ = Not statistically significant, numerical evidence in favor of reduced uptake.↔ = Not statistically significant, mixed or inconsistent evidence.Ø = No evidence. Quantitative factors associated with vaccine decisions during pregnancy in the UK. The factors were mapped to the theme pregnancy-specific issues, which was added to the SAGE matrix for the purpose of the current review. For studies with no evidence, results were not significant; the direction of numerical difference was reported. ↑ = Not statistically significant, numerical evidence in favor of increased uptake. ↓ = Not statistically significant, numerical evidence in favor of reduced uptake. ↔ = Not statistically significant, mixed or inconsistent evidence. Ø = No evidence. Contextual influences For contextual influences, the evidence was heterogeneous, with studies supporting associations between individual factors and both increased/reduced vaccine uptake as well as null findings (Table 4). Few studies reported evidence supporting associations between factors within the categories “communication and media environment”, and “influential leaders, gatekeepers and anti- or pro-vaccination lobbies” and vaccine uptake. The category “religion/culture/gender/socio-economic factors” was most commonly reported (n = 27 studies) with age (older age) and ethnicity (being White or Asian) associated with increased vaccine uptake, whereas level of deprivation (living in the most deprived areas) was associated with reduced vaccine uptake. The categories “disease- and disability-related” factors and “geography or timing” also showed some evidence of an association with vaccine uptake. One notable factor under “geography or timing” was location in the UK with country or region showing substantial evidence for an association with vaccine uptake. Women were more likely to accept influenza and COVID-19 vaccines in Wales and Scotland compared to England,68,71 whereas women in Northern Ireland were less likely to accept COVID-19 vaccines compared to England.71 Within England, studies found that uptake rates of COVID-19, influenza and pertussis vaccines were higher in regions outside London compared to London,37,57,62,71 with notably high uptake rates in East and West Midlands.57,71,76 Individual and group influences For individual and group influences, while the evidence was mostly associated with increases in vaccine uptake, it was also restricted due to the small number of studies (Table 5). The categories “experience with past vaccination” and “beliefs and attitudes” were most commonly reported (n = 7 studies each). Across the five categories, notable factors were having received a vaccine during current/last pregnancy, perceived susceptibility and severity of disease and information sources within the healthcare system, all favoring increased vaccine uptake. Pregnancy-specific issues For “pregnancy-specific issues,” the findings were also heterogeneous (Table 6). The level of evidence was considered weak due to several studies lacking significant results. However, a notable factor was prior pregnancies and the number of existing children, with six studies providing evidence for an association with increased vaccine uptake; that is, previous pregnancy and greater number of children associated with greater likelihood of deciding to get vaccinated.15,21,33,44,46,52 Additionally, later stages of pregnancy were also associated with an increase in vaccine uptake.39,71,77 Vaccination intention vs uptake Of the included studies, 27 reported actual vaccine uptake and 12 reported vaccination intention; eight studies reported both outcomes. Of these, 22 studies reported actual uptake35,37,39,42–47,50,51,57,59,62,68,70,72–76,79 and four reported vaccination intention using quantitative designs.36,48,71,77 The studies reporting both outcomes did not distinguish between the two outcomes (Figure 6). The comparison of factors influencing each of these outcomes first highlights considerable inconsistency in the factors measured between studies focussed on intention and uptake, respectively. This is evidenced by the fact that of the potential 114 factors that could be examined, only 31 factors were considered in relation to actual uptake, and 7 factors were considered in relation to vaccination intention and only 12 factors considered in relation to both outcomes. In view of differences in the number of studies to have measured each potential explanatory factor, Figure 6 also reports the percentages of studies reporting evidence of an association with either uptake or intention (irrespective of direction of the effect). This shows greater evidence in support of age, and reproductive history being related to uptake, compared with intention. In contrast, ethnicity, religion, deprivation and COVID-19 status were more likely to be associated with intention, rather than uptake. Although it should be noted that in many cases these comparisons are derived from very small numbers of studies on intention. Factors for which the evidence in support of influences on intentions and uptake was more consistent included presence of co-morbidities, geographical location, previous vaccination, information and stage of pregnancy. Quantitative factors associated with vaccine decisions during pregnancy in the UK. A comparison between the evidence for the association in studies using vaccination intention versus vaccine uptake as outcomes. Percentages indicate the proportion of studies observing an association. Discussion The aims of this scoping review were (1) to identify factors associated with vaccine decisions among pregnant women in the UK and map them to the SAGE matrix, (2) to examine differences in the identified factors across qualitative and quantitative evidence and (3) to examine the differences in how factors were associated with vaccination intention and actual vaccine uptake. In so doing, we have sought to identify gaps in the existing evidence base as well as signals which may support the development of interventions to promote vaccine uptake. Overall, the review identified 222 factors derived from qualitative research and 114 factors derived from quantitative research. The qualitative research provided an array of factors that largely centered around beliefs, attitudes and perceptions of the benefits, effectiveness and safety of vaccines. This was in addition to information sources; the role of healthcare professionals and the information provided along with whether or not vaccination was offered. These factors indicated a general uncertainty around maternal vaccination shaped by inconsistent communication and guidance from the healthcare system and government. However, the findings also indicated that healthcare professionals are key actors in providing accurate and reliable information supporting decision making around maternal vaccination. However, their role may be limited by the structural features of the healthcare and maternity care system and they may lack the skills and resources to inform pregnant women about maternal vaccines. In contrast, the quantitative evidence focussed mostly on non-modifiable individual characteristics underpinning maternal vaccination. Most evidence related to socio-demographic characteristics such as age, ethnicity, economic deprivation, location within the UK and reproductive history. Taken together, the qualitative studies provided in-depth insights into the reasons pregnant women may decide to take/refuse/delay vaccination, while the quantitative studies illuminated socio-demographic trends in these decisions. We also sought to compare influences on vaccine uptake versus vaccination intention. Although some differences were observed between these two outcomes, the most striking finding was the marked inconsistency in the factors assessed in studies of vaccine intentions versus vaccine uptake, thereby limiting comparisons. In the following sections, we seek to provide an interpretation of the main findings by integrating the qualitative and quantitative research included in the current review. Factors associated with vaccination decisions in pregnant women Contextual influences The contextual influences were dominated by barriers related to unreliable and inconsistent communication around the role and benefits of vaccination during pregnancy, which shaped beliefs and attitudes toward vaccines.34,36,50,65 Misinformation was reported across multiple communication channels, such as social and mainstream media as well as through healthcare professionals and the healthcare system.36,42,45,76 Mistrust emerged as a common mechanism across categories, including historical influences, politics and policies, and perceptions of the pharmaceutical industry, reflecting concerns due to past controversies and skepticism of vaccine development and approval processes.41,48,52,71 Structural features of maternity care and service accessibility were also prominent, indicating that vaccine decisions were also influenced by organizational factors within the healthcare system. The quantitative findings mostly examined sociodemographic characteristics, such as age, ethnicity, deprivation, health status and geographic location. These data indicated that vaccine uptake was higher in older women and women with White or Asian backgrounds, while living in the most deprived areas was associated with reduced vaccine uptake. Cultural and religious beliefs and not speaking English were also identified as barriers to accessing and engaging with vaccination information.78 For example, studies found that people of minority ethnic backgrounds and people living in highly deprived areas, who exhibit these characteristics, tended to show lower vaccine uptake rates.42,45,107,108 Integrating these findings with those from the qualitative studies may suggest that some of the socio-demographic differences (e.g., ethnicity, social and economic deprivation) in vaccine uptake could be due to greater exposure to misinformation, poorer access to healthcare professionals and the health service and greater mistrust in these social groups.43,76 Individual and group influences The qualitative findings highlighted a complex interaction between emotional responses, experiential reasoning, social norms and trust in the healthcare system that drive vaccine decisions among pregnant women. Barriers related to concerns about the safety of vaccines for the mother and the fetus, fear of long-term side effects, perceived low susceptibility to disease and beliefs in natural immunity. Additionally, uncertainty around the safety of vaccines elicited emotional responses and included anticipated guilt reflecting a strong sense of responsibility during pregnancy to protect the fetus.52,56,64,66,78 The quantitative studies partially mirrored the qualitative findings. Vaccine uptake was associated with similar emotional responses and experiential reasoning factors, including prior vaccination experiences, perceived benefits of vaccination, perceived disease severity, anticipated regret, and influence from healthcare professionals and close social networks. The heightened sense of responsibility and risk-sensitivity may add to the uncertainty, even if vaccines are recommended, adding to the need for more effective communication around the safety and effectiveness of vaccines.109,110 Past personal experiences with illness or vaccination and the views of partners, family members and peers also influenced perceptions, either reinforcing hesitancy or promoting acceptance.50,52,56,65,66 This supports other research showing that vaccine decisions may not be made in isolation, but involve a social component, where beliefs and knowledge are exchanged with others.93,111–113 Personal experiences with healthcare professionals were also identified as barriers. These included a lack of continuity of care with the same healthcare professionals throughout the pregnancy (e.g., midwife) or behaviors that reduced trust in the healthcare system, such as perceived judgment, dismissal or lack of transparency around vaccine safety. Such perceptions may foster mistrust and lead pregnant women to seek vaccine information from other sources, such as social media, which could further increase uncertainty or uninformed decisions.109,114,115 Taken together these findings suggest that mistrust in vaccine recommendations from the healthcare system may stem from a lack of supportive relationships and trustworthy communication with healthcare professionals, beyond recommendation of vaccines and provision of information alone. Vaccine- and vaccination-specific issues Factors under this theme were only reported in qualitative studies. This theme highlighted how features of vaccination programs influence the vaccine decisions in pregnant women, including how the programs were communicated and implemented. For example, for new vaccines or vaccine reformulations (e.g., as seen with COVID-19), there were concerns about limited pregnancy-specific evidence, uncertainty around long-term safety and changing or unclear guidance from the NHS.33,54,61,71 Similar challenges were evident in relation to the recently introduced RSV vaccine, where the novelty of the vaccination and the lack of evidence on long-term effects were some of the most important barriers to uptake in the beginning.36 However, it has been shown that the RSV uptake increased as the delivery systems became more established and training of healthcare professionals increased, both of which helped reduce concerns among pregnant women.116 The format of vaccine-related information was also found to influence vaccine decisions, with difficult (scientific) language, information exclusively in English and a reliance on digital communication all found to discourage vaccine uptake in some populations. Digital exclusion is particularly important as health information is increasingly transitioning to online formats, despite evidence suggesting that hard copy and face-to-face information are preferred among pregnant women.117,118 In contrast, access to clear, pregnancy-specific scientific information, availability of healthcare professionals for discussion, and routine recommendations embedded within antenatal care pathways were seen as enablers.52,58,66 These factors suggest that vaccination programs would benefit from communicating greater certainty and providing reassurance. Healthcare professionals therefore have a key role to play, potentially acting as both barriers and enablers. As with “individual and group influences”, limitations in continuity of care with the same healthcare professionals and confidence in the information provided emerged as barriers. However, when these factors were available, they were found to be influential enablers.119,120 These findings highlight that pregnant women’s decisions to vaccinate are also influenced by how vaccines are introduced, communicated and delivered as part of antenatal care pathways and the need for consistent guidance and trust in healthcare systems. Pregnancy-specific issues In the current review, an additional theme was added to capture factors specific to pregnant women that did not fit into existing SAGE matrix themes. The qualitative studies highlighted situational barriers unique to pregnancy, including disruptions to antenatal services during the COVID-19 pandemic, reluctance to receive vaccines while pregnant and heightened safety concerns. Similar to the other SAGE matrix themes, these findings reflected a heightened perception of risk during pregnancy, where decisions are framed not only in relation to maternal health but also potential consequences for the fetus. Quantitative studies partially mirrored these findings, identifying factors related to reproductive history, pregnancy risk status, complications, stage of pregnancy, and multiple gestations. Such factors suggest that women’s prior pregnancy experiences and current pregnancy/health status may shape vaccine decisions, where more experience is associated with lower risk perception and subsequently higher vaccine uptake. Vaccination intention vs actual uptake The overlap between factors examined in relation to vaccination intention and vaccine uptake was limited, and the overall evidence base, particularly for vaccination intention, was small. Nevertheless, there appears to be early evidence that factors associated with vaccination intentions were not always consistently associated with vaccine uptake and vice versa. Notable areas of consistent support included the importance of reliable information. Evidence gaps In this section we outline the evidence gaps identified in the current review. Limited data were captured from Wales (3 studies) and Northern Ireland (1 study). Only two studies reported on RSV vaccines, and only one of these reported exclusively on RSV vaccines, which likely reflects the relatively recent incorporation of this vaccine into recommendations for pregnant women in the UK. As such, the factors contributing to vaccine decisions related to the RSV vaccine in the UK require further investigation. Mode of administration, reliability and source of vaccine supply/equipment, and costs were not captured in the qualitative literature. Similarly, socio-demographic factors related to economic deprivation were reported in the quantitative literature, but little mention of these arose in the qualitative studies. This highlights a gap in our understanding regarding vaccine uptake among pregnant women in deprived areas, which would benefit from further qualitative research to better understand potential mechanisms. No studies directly captured the views of the partners of pregnant women, which may have an impact on maternal vaccine acceptance. Finally, although the current review sought to provide a UK-wide perspective, most of the included studies were conducted in England, with only a minority in Scotland, Wales and Northern Ireland. Given the devolved nature of the UK’s healthcare system (the NHS), this highlights a gap in the literature relating to the differences across the four countries, including policy, service delivery and population characteristics. Strengths and limitations The current review had several strengths. We took a comprehensive approach to mapping factors associated with vaccination decisions among pregnant women in the UK, with inclusion and parallel synthesis of qualitative and quantitative evidence and targeting multiple vaccine types and outcomes. We also applied the SAGE matrix as a theoretical framework to systematically guide the structure and interpretation of findings. By organizing factors into a meaningful conceptual categorization, the SAGE matrix enabled interpretation and direct translation into future research as well as policy. Finally, the UK-specific focus allowed us to contextualize the findings and reduce confounders relating to healthcare access, cost and culture. The UK operates a single publicly funded healthcare system (the NHS) with shared principles across regions and countries, including in relation to maternity care. The current review also had limitations. We followed a rapid review methodology, which may have increased the risk of selection bias. In addition, the current review aimed to distinguish between factors associated with actual vaccine uptake and intention. We aimed to examine whether differences existed in the factors associated with vaccination intentions and vaccine uptake. However, as only a small subset of potential factors was examined in relation to both intention and uptake, the results of this comparison should be interpreted with caution. We should also acknowledge that while the generalizability of our findings beyond the UK is unclear, many of the factors we observed to be relevant (e.g., ethnicity) have also been identified in reviews focussed on international evidence related to general population samples.121,122 Conclusions The current scoping review identified a comprehensive range of factors associated with vaccination decisions among pregnant women in the UK. The results indicates that clear and consistent communication is crucial for promoting maternal vaccines. Healthcare professionals were found to play a particularly important role in supporting women in making informed decisions around vaccination through trust and consistent care throughout the pregnancy period. Moreover, age, ethnicity, social and economic deprivation, and education levels appear to influence vaccine uptake among pregnant women, potentially due to poorer access to healthcare professionals and more access to misinformation through other channels (e.g., social media, family, peers). Together, these findings highlight the need to prioritize the delivery of trustworthy, consistent and reliable information about maternal vaccines to pregnant women, particularly for those in disadvantaged communities, and to provide antenatal consultations that allow sufficient time for engaged, in-depth discussions around any concerns. The role of healthcare professionals as the primary contact point with pregnant women needs to be strengthened by providing them with the necessary means to have supportive conversations with pregnant women (e.g., providing time and opportunity for conversations about vaccination, accessible training and access to up to date information regarding vaccinations). Future research should focus on strengthening the evidence base for the factors identified in the current review as well as exploring the public’s willingness for vaccinations to be regarded as a routine feature of antenatal care unless opted out. Supplementary Material Appendix 2_Search strategies.docx Appendix 3_QUAL_Factors mapped to SAGE matrix.docx Appendix 1_PRISMA ScR Checklist.docx Appendix 4_QUANTI_Factors mapped to SAGE matrix.docx Biography Kavita Vedhara is an academic health psychologist whose research has focussed on advancing our understanding of how psychological processes shape health and disease. Her work has elucidated how affective states such as stress and positive mood can alter immune function, increase susceptibility to infections, impede wound healing and influence vaccine responses. Her work also examines psychological determinants of health behaviors, particularly those associated with reducing risk of infectious diseases and cancers (e.g., cancer screening, engagement with facemasks, vaccine uptake etc.). Her work is both interdisciplinary and translational in nature, driven by a focus on identifying the ways psychological and behavioral factors can be harnessed to improve the health and well-being of patients and the public. Funding Statement The author(s) reported there is no funding associated with the work featured in this article. Disclosure statement No potential conflict of interest was reported by the author(s). Supplementary material Supplemental data for this article can be accessed online at https://doi.org/10.1080/21645515.2026.2687220 References Associated Data Supplementary Materials Appendix 2_Search strategies.docx Appendix 3_QUAL_Factors mapped to SAGE matrix.docx Appendix 1_PRISMA ScR Checklist.docx Appendix 4_QUANTI_Factors mapped to SAGE matrix.docx